Laronidase hypersensitivity and desensitization in type I mucopolysaccharidosis: A case report

Pediatric Allergy and Immunology

Volumn 25, Issue 5, 2014, Pages 498-499

  Ensina, Luis Felipe ^a   Aranda, Carolina Sanchez ^a   de Lacerda, Alex Eustáquio ^a   Camelo Nunes, Inês ^a   Solé, Dirceu ^a   Martins, Ana Maria ^a   Castells, Mariana ^b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LARONIDASE; LEVO IDURONIDASE;

CASE REPORT; CHILD; DESENSITIZATION; DRUG HYPERSENSITIVITY; ENZYME REPLACEMENT; FEMALE; HUMAN; LETTER; MUCOPOLYSACCHARIDOSIS; PRIORITY JOURNAL; SCHOOL CHILD; SWELLING; URTICARIA; IMMUNOLOGY; MUCOPOLYSACCHARIDOSIS I; PROCEDURES;

CHILD; DESENSITIZATION, IMMUNOLOGIC; DRUG HYPERSENSITIVITY; ENZYME REPLACEMENT THERAPY; FEMALE; HUMANS; IDURONIDASE; MUCOPOLYSACCHARIDOSIS I;

EID: 84907598003     PISSN: 09056157     EISSN: 13993038     Source Type: Journal    
DOI: 10.1111/pai.12209     Document Type: Letter

References (8)

1. de Ru MH, Boelens JJ, Das AM, et al. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure. Orphanet J Rare Dis 2011: 6 : 55.
2. Giugliani R, Federhen A, Rojas MVM, et al. Mucopolysaccharidosis I, II, and VI: brief review and guidelines for treatment. Genet Mol Biol 2010: 33 : 589-604.
3. Castells MC, Tennant NM, Sloane DE, et al. Hypersensitivity reactions to chemotherapy: outcomes and safety of rapid desensitization in 413 cases. J Allergy Clin Immunol 2008: 122 :574-80.
4. Clarke LA, Wraith JE, Beck M, et al. Long-term efficacy and safety of laronidase in the treatment of mucopolysaccharidosis I. Pediatrics 2009: 123: 229-40.
5. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002: 57: 45-51.
6. Cernadas JR, Brockow K, Romano A, et al. General considerations on rapid desensitization for drug hypersensitivity - a consensus statement. Allergy 2010: 65 : 1357-66.
7. El-Gharbawy AH, Mackey J, DeArmey S, et al. An individually, modified approach to desensitize infants and young children with Pompe disease, and significant reactions to alglucosidase alfa infusions. Mol Genet Metab 2011: 104: 118-22.
8. Serrano CD, Gomez JF. Successful desensitization to idursulfase in a patient with type II mucopolysaccharidosis (Hunter syndrome). J Investig Allergol Clin Immunol 2011: 21: 571-2.